🦠
MicroDAO Whitepaper
  • MICRO: Funding the next generation of AMR Solutions: Antimicrobials, Diagnostics, and Vaccines
    • Executive Summary
    • The AMR Challenge
      • Understanding Antimicrobial Resistance
      • The Human Innovation Gap
      • Investments into AMR solutions
    • microDAO: A Community-Driven Solution to Tackle AMR
      • Vision and Mission
      • Operational Framework
      • Structure of microDAO
        • Core Team
        • Community Members
        • Token Holders
        • Working Groups
        • Service Providers
        • Partners
        • End users of solutions and funding offered by microDAO
    • DAO Way of Working
    • microDAO’s Flywheel for Impact and Revenue: Community Tools and Workflows
      • Evidence Generation & Decision Support Tools
      • R&D Acceleration Tools
    • microDAO Revenue Streams: Building Sustainable Impact
    • Fund Allocation Strategy for liquid funds available in the DAO treasury
      • Strategic Priority Areas
        • Early-Stage Research Development
        • Clinical Development Support
        • Equitable Access Programmes
        • Infrastructure and Tools
        • Operational Sustainability
    • Impact and Future Outlook
Powered by GitBook
On this page
  1. MICRO: Funding the next generation of AMR Solutions: Antimicrobials, Diagnostics, and Vaccines

DAO Way of Working

Key aspects of a DAO way of working include:

  • Community Governance and Decision-making: MicroDAO empowers its stakeholders to participate in governance rather than relying on a central authority. Decisions about funding, projects, and strategy are made collectively, with voting rights distributed among MICRO token-holding members based on predetermined rules. This ensures that diverse voices are heard and that the direction of the organisation reflects the interests and insights of its community.

  • Transparent allocation of funds: All financial transactions within the DAO are recorded on a blockchain, ensuring transparency in how funds are allocated.

  • Collaborative partnerships with researchers, institutions, and industry: microDAO aims to generate a collaborative environment and bring together stakeholders from all stages: research, development and commercialisation to support the continual development of antimicrobials, diagnostics and vaccines and help us stay a few steps ahead of emergent resistance.

PreviousEnd users of solutions and funding offered by microDAONextmicroDAO’s Flywheel for Impact and Revenue: Community Tools and Workflows

Last updated 6 months ago